Europe Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
Europe cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The Europe cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 2,370.5 million in 2024.
- The market is expected to grow at a CAGR of 5.6% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2025 to 2035.
Europe data book summary
| Market revenue in 2024 | USD 2,370.5 million |
| Market revenue in 2035 | USD 4,252.7 million |
| Growth rate | 5.6% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.1% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2035.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,288.6 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 51.05% in 2024. Horizon Databook has segmented the Europe cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
Europe holds the second-largest share of the cervical cancer screening, diagnostics, and precancerous dysplasia lesion treatment market, propelled by robust government initiatives. According to the WHO, more than 66,000 women in the WHO European Region are diagnosed with cervical cancer annually, with over 30,000 succumbing to the disease.
In August 2020, the World Health Assembly adopted the Global Strategy to eliminate cervical cancer as a public health problem, marking the first global commitment to eradicating a cancer. Building on this momentum, the WHO European Region introduced the Roadmap to Accelerate Elimination of Cervical Cancer (2022–2030), which aims to secure universal access to HPV vaccination, screening, and treatment services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Europe cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market size, by country, 2018-2035 (US$M)
Europe Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
